Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Total Liabilities: 2019-2022

Historic Total Liabilities for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2022 value amounting to $411.4 million.

  • ADC Therapeutics' Total Liabilities rose 22.04% to $521.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.9 billion, marking a year-over-year increase of 11.28%. This contributed to the annual value of $411.4 million for FY2022, which is 8.96% down from last year.
  • According to the latest figures from FY2022, ADC Therapeutics' Total Liabilities is $411.4 million, which was down 8.96% from $451.9 million recorded in FY2021.
  • In the past 5 years, ADC Therapeutics' Total Liabilities registered a high of $451.9 million during FY2021, and its lowest value of $26.5 million during FY2019.
  • Its 2-year average for Total Liabilities is $431.6 million, with a median of $431.6 million in 2021.
  • Data for ADC Therapeutics' Total Liabilities shows a maximum YoY decreased of 8.96% (in 2022) over the last 5 years.
  • Yearly analysis of 3 years shows ADC Therapeutics' Total Liabilities stood at $26.5 million in 2019, then reached $451.9 million in 2021, then fell by 8.96% to $411.4 million in 2022.